[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343028-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-343028-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","endogenous-and-exogeneous-stimuli-triggered-reactive-oxygen-species-evoke-long-lived-carbon-monoxide-to-fight-against-lung-cancer","Endogenous and exogeneous stimuli-triggered reactive oxygen species evoke long-lived carbon monoxide to fight against lung cancer","","Reactive oxygen species (ROS)-based anticancer strategies are limited by insufficient ROS levels and short ROS half-life, and both issues have not been addressed simultaneously. A multichannel nanotherapeutic platform using hollow manganese dioxide carriers loads chlorin e6 (Ce6) and a CO donor to maximize ROS accumulation and catalytically generate CO. Intratumoral H2O2 and ultrasound act as endogenous and exogeneous triggers to produce •OH and 1O2, converting short-lived ROS into long-lived CO. CO-mediated AKT signaling activation, NRF-2 phosphorylation, and HMOX-1 overexpression drive mitochondrial dysfunction, suppressing lung cancer progression, recurrence, and metastasis while extending survival.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/endogenous-and-exogeneous-stimuli-triggered-reactive-oxygen-species-evoke-long-lived-carbon-monoxide-to-fight-against-lung-cancer/343028/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/endogenous-and-exogeneous-stimuli-triggered-reactive-oxygen-species-evoke-long-lived-carbon-monoxide-to-fight-against-lung-cancer/343028.png","ImageObject",300,407,{"name":42,"@type":43},"Liam","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem do ROS-based anticancer approaches face in this study?","Question",{"text":63,"@type":64},"They often suffer from insufficient ROS levels and a short ROS half-life.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is long-lived carbon monoxide generated in the proposed platform?",{"text":68,"@type":64},"A hollow manganese dioxide carrier loads Ce6 and a CO donor, while intratumoral H2O2 and ultrasound trigger ROS production and cascade catalysis to release CO.",{"name":70,"@type":61,"acceptedAnswer":71},"What molecular effects does CO have to enhance anti-tumor outcomes?",{"text":72,"@type":64},"Proteomic and genomic investigations indicate CO activates AKT signaling, increases NRF-2 phosphorylation, and overexpresses HMOX-1, inducing mitochondrial dysfunction.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343028,1791096527,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Fang et al. Journal of Nanobiotechnology (2024) 22:416  \n[https://doi.org/10.1186/s12951-024-02688-x](https://doi.org/10.1186/s12951-024-02688-x)  \nJournal of Nanobiotechnology  \n RESEARCH Open Access  \nEndogenous and exogeneous  \nstimuli-triggered reactive oxygen species evoke long-lived carbon monoxide to fight against lung cancer  \nYujia Fang1, Jianjun Yang2, Xiayi Liang2,3, Jing Wu1, Mengqing Xie1, Kun Zhang2,3* and Chunxia Su1*  \nAbstract  \nReactive oxygen species (ROS)-associated anticancer approaches usually suffer from two limitations, i. e., insufficient ROS level and short ROS half-life. Nevertheless, no report has synchronously addressed both concerns yet. Herein, a multichannel actions-enabled nanotherapeutic platform using hollow manganese dioxide (H-MnO2) carriers to load chlorin e6 (Ce6) sonosensitizer and CO donor (e.g., Mn2(CO) 10) has been constructed to maximumly elevate ROS level and trigger cascade catalysis to produce CO. Therein, intratumoral H2O2 and ultrasound as endogenous and exogeneous triggers stimulate H-MnO2 and Ce6 to produce •OH and 1O2, respectively. The further cascade reaction between ROS and Mn2(CO) 10 proceeds to release CO, converting short-lived ROS into long-lived CO. Contributed by them, such a maximumly-elevated ROS accumulation and long-lived CO release successfully suppresses the progression, recurrence and metastasis of lung cancer with a prolonged survival rate. More significantly, proteomicand genomic investigations uncover that the CO-induced activation of AKT signaling pathway, NRF-2 phosphorylation and HMOX-1 overexpression induce mitochondrial dysfunction to boost anti-tumor consequences. Thus, this cascade catalysis strategy can behave as a general means to enrich ROS and trigger CO release against refractory cancers. Keywords Reactive oxygen species, Long half-life, Lung cancer, Carbon monoxide, Cascade catalysis  \n*Correspondence: Kun Zhang [zhang1986kun@126.com](zhang1986kun@126.com)[ ](zhang1986kun@126.com)Chunxia Su[susu_mail@126.com](susu_mail@126.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[http://creativeco](http://creativeco)[mmons.org/publicdomain/zero/1.0/](mmons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nFang et al. Journal of Nanobiotechnology (2024) 22:416 Page 2 of 16  \nGraphic Abstract  \nIntroduction  \nLung cancer is famous for high incidence and low cure rate, and has become the important cause of cancer-arsed deaths worldwide [1]. For intermediate and advanced cancers, the advent of targeted therapies and immunotherapies has improved the prognosis for most patients, but they still suffer from drug resistance and over-progression. The tremendous advances in nanomedicine and nanobiotechnology provide a highly promising r","cbCaiaPmsobHaixP","https://ap.wps.com/l/cbCaiaPmsobHaixP","pdf",10444958,16,"English","# Abstract\n# Introduction","[{\"question\":\"What problem do ROS-based anticancer approaches face in this study?\",\"answer\":\"They often suffer from insufficient ROS levels and a short ROS half-life.\"},{\"question\":\"How is long-lived carbon monoxide generated in the proposed platform?\",\"answer\":\"A hollow manganese dioxide carrier loads Ce6 and a CO donor, while intratumoral H2O2 and ultrasound trigger ROS production and cascade catalysis to release CO.\"},{\"question\":\"What molecular effects does CO have to enhance anti-tumor outcomes?\",\"answer\":\"Proteomic and genomic investigations indicate CO activates AKT signaling, increases NRF-2 phosphorylation, and overexpresses HMOX-1, inducing mitochondrial dysfunction.\"}]","Endogenous and exogeneous stimuli-triggered reactive oxygen species evoke long-lived carbon monoxide to fight against lung cancer | PDF",1790049478,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f335f4cb86a032fb42e46b2c1c449cd.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5114742ece9196f13d77952082c714a7.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2c57149f72e48c7f55b0ee820095fe0.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8eb7dc242fc2e2c190e6916e193725df.webp",980,1301]